entity

TDP-43_aggregation

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about TDP-43_aggregation: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

13Connections
1Hypotheses
1Analyses
4Outgoing
9Incoming
0Experiments
1Debates

No AI portrait yet

Outgoing (4)

TargetRelationTypeStr
neuroinflammationcontributes_tomechanism0.78
neurodegenerationcontributes_todisease0.75
glymphatic_clearanceassociated_withmechanism0.75
mitochondrial_dysfunctionassociated_withmechanism0.75

Incoming (9)

SourceRelationTypeStr
HSP70preventsprotein0.80
glymphatic_clearancemediatesmechanism0.80
TREM2_proteincorrelates_withprotein0.75
microglial_activationassociated_withmechanism0.75
oxidative_stresscontributes_tophenotype0.75

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Cytosolic TDP-43 aggregation sequesters SNAP29 and syntaxin- 0.600 neurodegeneration What are the neuron-specific effects of

Mentioning Analyses (1)

Scientific analyses that reference this entity

TDP-43 phase separation therapeutics for ALS-FTD

neurodegeneration | 2026-04-01 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (1)

Multi-agent debates referencing this entity

What are the mechanisms underlying tdp-43 phase separation therapeutics for als-

closed · Rounds: 4 · Score: 0.95 · 2026-04-01

Related Research

Hypotheses and analyses mentioning TDP-43_aggregation in their description or question text

No additional research found